Apak-212 Official

The study of APAK and related constructs like APAK-212 is central to several areas of oncology:

: When DNA damage occurs, the ATM (ataxia-telangiectasia mutated) kinase phosphorylates APAK at specific sites (e.g., Ser68), causing it to dissociate from p53. This release allows p53 to activate genes like p53AIP1 , which initiate apoptosis. Characteristics of APAK-212 APAK-212

The construct is a research-grade tool designed to mimic or interfere with these interactions. Based on its classification in preclinical literature, it typically features: The study of APAK and related constructs like

: It often incorporates specific domains from the natural APAK protein, such as the zinc finger motifs or the KRAB domain, to target the p53 interaction interface. Based on its classification in preclinical literature, it

: It is used to study how p53-dependent pathways can be "re-awakened" in cancer cells or protected in normal cells during stress. By manipulating the APAK-p53 bond, researchers can investigate the protein’s role in tumor survival and its potential as a therapeutic target. Applications in Preclinical Research

APAK-212 refers to a synthetic, modular peptide-based construct primarily used in preclinical molecular biology and cancer research. It is specifically designed as a pharmacological tool to modulate the , a KRAB-type zinc finger protein (also known as ZNF420) that acts as a natural negative regulator of p53-mediated apoptosis. Overview of APAK (ZNF420)

: Because APAK specifically regulates the apoptotic function of p53 without affecting its cell-cycle arrest function, it is viewed as a highly specific target for drugs aimed at sensitizing cancer cells to chemotherapy without damaging healthy, non-dividing cells.